south korea peptic ulcer market

South Korea Peptic Ulcer Market: Segmented By Drug Class (Proton Pump Inhibitors [PPIs], Antihistamines, H2 Antagonists, Antacids, Antibiotics And Others) and By Clinical Application (Gastric Ulcers, Duodenal Ulcer, Oesophageal Ulcer) - Growth, Trends and Forecasts (2019 2028)

  • Published Date: 2022-12-13
  • Report ID: 141709
  • Pages: 200
  • Format: prudent report format

Report Overview

The South Korea peptic ulcer market size stood at around USD 721.7 million in 2019 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx% during the forecast period.

Peptic ulcers are open sores that develop on the inside lining of stomach and the upper portion of small intestine. The most common causes of peptic ulcers are infection with the bacterium Helicobacter pylori (H. pylori) and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen sodium. Stress and spicy foods do not cause peptic ulcers. However, they can make the symptoms worse. Most common symptoms are burning stomach pain, feeling of fullness, bloating, or belching, intolerance to fatty foods, heartburn, and nausea. Peptic ulcer is one of the most commonly encountered gastroenterological diseases in Korea.



Market Drivers

The major driving factors for peptic ulcers drug market are increase in the stress and drug induced ulcers. Growing rate of infection by H. Pylori, changes in food, rise in cancer, tobacco and alcohol use are propelling factors for this market. Restraining factors of this market are expiry of patent, H. Pylori resistance and extreme market fragmentation.


1. South Korea Peptic Ulcer Market Overview.
A. Market Size
2. Market Growth Drivers.
A. Increase in Stress and Drug Induced Ulcers
B. Growing Rate of H. Pylori Infection
3. Epidemiology of Peptic Ulcer......................................
A. Prevalence
B. Incidence
4. Peptic Ulcer Market Segmentation.
A. Drug Class
I. Proton Pump Inhibitors (PPIs)
II. Antihistamines
III. H2 Antagonists
IV. Antacids
V. Antibiotics
VI. Others
B. Clinical Application
I. Gastric Ulcers
II. Duodenal Ulcer
III. Oesophageal Ulcer
5. Peptic Ulcer Products Market Share.
A. Market Analysis, Insights and Forecast By Revenue
6. Competitive Landscape...
A. Major Players
B. Products in Pipeline
7. Key Company Profiles.
A. Takeda Pharmaceuticals Korea Company Overview, Product & Services, Strategies & Financials
B. Daewoong Pharmaceuticals Company Overview, Product & Services, Strategies & Financials
C. Hanmi Pharmaceutical Company Overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth
A. New Trends and Development of Peptic Ulcer Market
B. Future Opportunities
10. Conclusion

 
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.